1240 related articles for article (PubMed ID: 33671004)
1. Heme Oxgenase-1, a Cardinal Modulator of Regulated Cell Death and Inflammation.
Ryter SW
Cells; 2021 Feb; 10(3):. PubMed ID: 33671004
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase-1/carbon monoxide as modulators of autophagy and inflammation.
Ryter SW
Arch Biochem Biophys; 2019 Dec; 678():108186. PubMed ID: 31704095
[TBL] [Abstract][Full Text] [Related]
3. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
Woo Y; Lee HJ; Jung YM; Jung YJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
[TBL] [Abstract][Full Text] [Related]
4. Heme oxygenase-1, a critical arbitrator of cell death pathways in lung injury and disease.
Morse D; Lin L; Choi AM; Ryter SW
Free Radic Biol Med; 2009 Jul; 47(1):1-12. PubMed ID: 19362144
[TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase and renal disease.
Jarmi T; Agarwal A
Curr Hypertens Rep; 2009 Feb; 11(1):56-62. PubMed ID: 19146802
[TBL] [Abstract][Full Text] [Related]
6. A Dual Role of Heme Oxygenase-1 in Cancer Cells.
Chiang SK; Chen SE; Chang LC
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583467
[TBL] [Abstract][Full Text] [Related]
7. Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice.
Carchman EH; Rao J; Loughran PA; Rosengart MR; Zuckerbraun BS
Hepatology; 2011 Jun; 53(6):2053-62. PubMed ID: 21437926
[TBL] [Abstract][Full Text] [Related]
8. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
[TBL] [Abstract][Full Text] [Related]
9. Heme oxygenase-1 expression in disease states.
Deshane J; Wright M; Agarwal A
Acta Biochim Pol; 2005; 52(2):273-84. PubMed ID: 15933765
[TBL] [Abstract][Full Text] [Related]
10. The role of heme oxygenase-1 in pulmonary disease.
Fredenburgh LE; Perrella MA; Mitsialis SA
Am J Respir Cell Mol Biol; 2007 Feb; 36(2):158-65. PubMed ID: 16980551
[TBL] [Abstract][Full Text] [Related]
11. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion Injury.
Cheng Y; Rong J
Curr Pharm Des; 2017; 23(26):3884-3898. PubMed ID: 28412905
[TBL] [Abstract][Full Text] [Related]
13. Heme oxygenase-1 and carbon monoxide in pulmonary medicine.
Slebos DJ; Ryter SW; Choi AM
Respir Res; 2003; 4(1):7. PubMed ID: 12964953
[TBL] [Abstract][Full Text] [Related]
14. Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders.
Ryter SW
Antioxidants (Basel); 2022 Mar; 11(3):. PubMed ID: 35326205
[TBL] [Abstract][Full Text] [Related]
15. Heme Oxygenase-1 and Autophagy Linked for Cytoprotection.
Vasconcellos LR; Siqueira MS; Moraes R; Carneiro LA; Bozza MT; Travassos LH
Curr Pharm Des; 2018; 24(20):2311-2316. PubMed ID: 30051776
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Heme Oxygenase-1 and Carbon Monoxide in Acute Organ Injury, Critical Illness, and Inflammatory Disorders.
Ryter SW
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33228260
[TBL] [Abstract][Full Text] [Related]
17. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation.
Ryter SW; Choi AM
Transl Res; 2016 Jan; 167(1):7-34. PubMed ID: 26166253
[TBL] [Abstract][Full Text] [Related]
18. Regulated cell death pathways in cardiomyopathy.
Sheng SY; Li JM; Hu XY; Wang Y
Acta Pharmacol Sin; 2023 Aug; 44(8):1521-1535. PubMed ID: 36914852
[TBL] [Abstract][Full Text] [Related]
19. Curcumin-induced heme oxygenase-1 expression prevents H2O2-induced cell death in wild type and heme oxygenase-2 knockout adipose-derived mesenchymal stem cells.
Cremers NA; Lundvig DM; van Dalen SC; Schelbergen RF; van Lent PL; Szarek WA; Regan RF; Carels CE; Wagener FA
Int J Mol Sci; 2014 Oct; 15(10):17974-99. PubMed ID: 25299695
[TBL] [Abstract][Full Text] [Related]
20. MLKL: Functions beyond serving as the Executioner of Necroptosis.
Zhan C; Huang M; Yang X; Hou J
Theranostics; 2021; 11(10):4759-4769. PubMed ID: 33754026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
